Jul 26, 2019 Roth Capital Partners Acts as Co-Manager for Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) in its $75 Million IPO Roth Capital Partners
Jul 25, 2019 Roth Capital Partners acts as a Co-Manager for Medallia, Inc. (NYSE: MDLA) in its $374.3 Million IPO Roth Capital Partners
Jul 24, 2019 Roth Capital Partners Acts as Financial Advisor for the Merger between NeuBase Therapeutics, Inc. (NBSE) & Ohr Pharmaceutical, Inc. (OHRP) Roth Capital Partners
Jun 28, 2019 Roth Capital Partners Acts as Co-Manager for ArQule, Inc. (Nasdaq:ARQL) in its $103.7 Million Follow-On Roth Capital Partners
Jun 26, 2019 Roth Capital Partners Acts as Lead Manager for Akero Therapeutics, Inc. (NASDAQ: AKRO) in its $105.8 Million IPO Roth Capital Partners
Jun 25, 2019 Roth Capital Partners Acts as Lead Placement Agent For ContraVir Pharmaceuticals, Inc. (NASDAQ:CTRV) in its $15.6 Million Follow-On Roth Capital Partners
Jun 24, 2019 Roth Capital Partners Acts as Joint Book-Running Manager for SharpSpring, Inc. (Nasdaq: SHSP) in its $26.7 Million Secondary Offering Roth Capital Partners
Jun 13, 2019 Roth Capital Partners Acts as Sole Manager for Charles & Colvard, Ltd. (Nasdaq: CTHR) in its $10 Million Follow-On Roth Capital Partners
Jun 12, 2019 Roth Capital Partners to Host 5th Annual ROTH London Conference on June 17- 19, 2019 in London, UK Business Wire
